| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in tumor vascular growth inhibition
|
Zhang, Keyong
|
|
|
26 |
9 |
p. 2084-2096
|
artikel
|
| 2 |
A review of dose escalation for FDA-approved products treating solid tumors and hematological malignancies in first-in-human trials
|
Jiang, Zehui
|
|
|
26 |
9 |
p. 2116-2125
|
artikel
|
| 3 |
Association between thyroid disorders and extra-thyroidal cancers, a review
|
Jia, Xin
|
|
|
26 |
9 |
p. 2075-2083
|
artikel
|
| 4 |
Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures
|
Chang, Lidan
|
|
|
26 |
9 |
p. 2323-2338
|
artikel
|
| 5 |
Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)
|
González Caraballo, Irene
|
|
|
26 |
9 |
p. 2388-2392
|
artikel
|
| 6 |
Clinical features and treatment outcomes of PD-1 inhibitor therapy in elderly patients (≥ 65 years) with advanced esophageal squamous cell carcinoma: a real-world study
|
Yu, Yi
|
|
|
26 |
9 |
p. 2360-2368
|
artikel
|
| 7 |
Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma
|
Liao, Zhaohui
|
|
|
26 |
9 |
p. 2309-2322
|
artikel
|
| 8 |
Correction: Logistic regression and other statistical tools in diagnostic biomarker studies
|
Elkahwagy, Dina Mohamed Ahmed Samir
|
|
|
26 |
9 |
p. 2393
|
artikel
|
| 9 |
Current status of neoadjuvant immunotherapy for the treatment of gastric cancer
|
Zhang, Xijie
|
|
|
26 |
9 |
p. 2097-2108
|
artikel
|
| 10 |
Development and validation of a novel scoring system based on a nomogram for predicting inadequate bowel preparation
|
Zhao, Xiaxia
|
|
|
26 |
9 |
p. 2262-2273
|
artikel
|
| 11 |
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer
|
Juan-Ribelles, Antonio
|
|
|
26 |
9 |
p. 2351-2359
|
artikel
|
| 12 |
Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer
|
Mi, Song
|
|
|
26 |
9 |
p. 2339-2350
|
artikel
|
| 13 |
Enhanced outcomes in residual or recurrent craniopharyngioma: evaluating combined gamma knife and phosphorus-32 brachytherapy
|
Ma, Jie
|
|
|
26 |
9 |
p. 2198-2204
|
artikel
|
| 14 |
Evolution of radiation-induced dermatitis treatment
|
Guangmei, Deng
|
|
|
26 |
9 |
p. 2142-2155
|
artikel
|
| 15 |
Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer
|
Lu, Wenhao
|
|
|
26 |
9 |
p. 2369-2379
|
artikel
|
| 16 |
Exploring research progress in studying serum exosomal miRNA-21 as a molecular diagnostic marker for breast cancer
|
Li, Hang
|
|
|
26 |
9 |
p. 2166-2171
|
artikel
|
| 17 |
Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma
|
Li, Chunhong
|
|
|
26 |
9 |
p. 2274-2295
|
artikel
|
| 18 |
Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma
|
Shi, Juanyi
|
|
|
26 |
9 |
p. 2181-2197
|
artikel
|
| 19 |
In vivo safety evaluation method for nanomaterials for cancer therapy
|
Chen, Mengqi
|
|
|
26 |
9 |
p. 2126-2141
|
artikel
|
| 20 |
Logistic regression and other statistical tools in diagnostic biomarker studies
|
Elkahwagy, Dina Mohamed Ahmed Samir
|
|
|
26 |
9 |
p. 2172-2180
|
artikel
|
| 21 |
Machine learning-driven prediction of brain metastasis in lung adenocarcinoma using miRNA profile and target gene pathway analysis of an mRNA dataset
|
Koh, Young Wha
|
|
|
26 |
9 |
p. 2296-2308
|
artikel
|
| 22 |
Molecular characterization of Chinese patients with small bowel adenocarcinoma
|
Jin, Bryan
|
|
|
26 |
9 |
p. 2205-2216
|
artikel
|
| 23 |
Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration
|
Fuchs, Vered
|
|
|
26 |
9 |
p. 2227-2239
|
artikel
|
| 24 |
Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway
|
Fu, Zi-Yi
|
|
|
26 |
9 |
p. 2250-2261
|
artikel
|
| 25 |
Prevalence and risk factors of thyroid nodules in breast cancer women with different clinicopathological characteristics: a cross-sectional study
|
Ma, Chen-yu
|
|
|
26 |
9 |
p. 2380-2387
|
artikel
|
| 26 |
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study
|
Falcón González, Alejandro
|
|
|
26 |
9 |
p. 2217-2226
|
artikel
|
| 27 |
Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy
|
Borregón, Miguel
|
|
|
26 |
9 |
p. 2109-2115
|
artikel
|
| 28 |
The effect of metabolic syndrome on prognosis of diffuse large B-cell lymphoma
|
Xiong, Wenjing
|
|
|
26 |
9 |
p. 2240-2249
|
artikel
|
| 29 |
The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review
|
Da, Wenxin
|
|
|
26 |
9 |
p. 2156-2165
|
artikel
|
Tijdschrift beschrijving